细菌性肺炎-话题@MedSci - 梅斯（MedSci）

#细菌性肺炎#

17篇内容 | 1304人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2228804, encodeId=aacd222880476, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a> <a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=多重耐药革兰氏阴性菌肺炎病原学、危险因素和耐药机制, objectType=article, longId=844448, objectId=84e9844448db, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240730/1722330274156_8538692.jpg, objectUrl=/article/show_article.do?id=84e9844448db, replyNumber=0, likeNumber=72, createdTime=2024-10-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=84e9844448db, moduleTitle=多重耐药革兰氏阴性菌肺炎病原学、危险因素和耐药机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=84e9844448db)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1469826, encodeId=6352146982607, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关, objectType=article, longId=301501, objectId=949930150182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=949930150182, replyNumber=0, likeNumber=0, createdTime=2022-03-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=949930150182, moduleTitle=J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=949930150182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469825, encodeId=81031469825bf, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=AJRCCM：新冠肺炎机械通气患者继发细菌性肺炎的患病率？, objectType=article, longId=218952, objectId=a2c1218952e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c1218952e2, replyNumber=0, likeNumber=86, createdTime=2021-10-22, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c1218952e2, moduleTitle=AJRCCM：新冠肺炎机械通气患者继发细菌性肺炎的患病率？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a2c1218952e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469824, encodeId=8258146982461, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, objectType=article, longId=204118, objectId=286220411867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286220411867, replyNumber=0, likeNumber=0, createdTime=2020-12-05, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286220411867, moduleTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=286220411867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469823, encodeId=0b1914698236c, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, objectType=article, longId=201780, objectId=b102201e8073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b102201e8073, replyNumber=0, likeNumber=77, createdTime=2020-10-08, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b102201e8073, moduleTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b102201e8073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469822, encodeId=9f1a1469822e2, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=FDA批准默沙东的抗生素组合Recarbrio，治疗细菌性肺炎, objectType=article, longId=195446, objectId=495f195446c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495f195446c7, replyNumber=0, likeNumber=71, createdTime=2020-06-09, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495f195446c7, moduleTitle=FDA批准默沙东的抗生素组合Recarbrio，治疗细菌性肺炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=495f195446c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469821, encodeId=e219146982143, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, objectType=article, longId=193655, objectId=d3a919365588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a919365588, replyNumber=0, likeNumber=67, createdTime=2020-05-09, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a919365588, moduleTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d3a919365588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469820, encodeId=bdfc1469820cb, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=RECARBRIO（亚胺培南、西司他丁和雷巴坦）或能“力克”呼吸机相关细菌性肺炎, objectType=article, longId=193628, objectId=177619362885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=177619362885, replyNumber=0, likeNumber=60, createdTime=2020-05-08, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=177619362885, moduleTitle=RECARBRIO（亚胺培南、西司他丁和雷巴坦）或能“力克”呼吸机相关细菌性肺炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=177619362885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469819, encodeId=ac0514698197a, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, objectType=article, longId=190910, objectId=dce919091038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce919091038, replyNumber=0, likeNumber=72, createdTime=2020-03-28, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce919091038, moduleTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dce919091038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469818, encodeId=fe86146981889, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=实体器官移植术后感染诊疗技术规范（2019版） ——总论与细菌性肺炎, objectType=article, longId=176107, objectId=e4011e61079b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4011e61079b, replyNumber=0, likeNumber=51, createdTime=2019-07-25, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4011e61079b, moduleTitle=实体器官移植术后感染诊疗技术规范（2019版） ——总论与细菌性肺炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e4011e61079b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469817, encodeId=4ee4146981e3b, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究, objectType=article, longId=175764, objectId=783b1e5764e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=783b1e5764e6, replyNumber=0, likeNumber=71, createdTime=2019-07-20, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=783b1e5764e6, moduleTitle=细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=783b1e5764e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469816, encodeId=2742146981636, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=Merck的抗生素Zerbaxa获得了FDA批准用于治疗医院获得性和呼吸机相关细菌性肺炎, objectType=article, longId=167634, objectId=b63116e634f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b63116e634f3, replyNumber=0, likeNumber=0, createdTime=2019-06-06, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b63116e634f3, moduleTitle=Merck的抗生素Zerbaxa获得了FDA批准用于治疗医院获得性和呼吸机相关细菌性肺炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b63116e634f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469815, encodeId=857a146981546, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, objectType=article, longId=160894, objectId=0a9b1608940f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9b1608940f, replyNumber=0, likeNumber=74, createdTime=2019-02-25, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9b1608940f, moduleTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a9b1608940f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469814, encodeId=a76d146981440, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=NEJM：Omadacycline治疗社区获得性细菌性肺炎, objectType=article, longId=159830, objectId=f247159830a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f247159830a2, replyNumber=0, likeNumber=95, createdTime=2019-02-14, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f247159830a2, moduleTitle=NEJM：Omadacycline治疗社区获得性细菌性肺炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f247159830a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469813, encodeId=7ea014698134e, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=【AHA2018】细菌性肺炎比病毒性肺炎对心脏的危害更大, objectType=article, longId=153467, objectId=19e115346ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e115346ece, replyNumber=0, likeNumber=67, createdTime=2018-11-15, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e115346ece, moduleTitle=【AHA2018】细菌性肺炎比病毒性肺炎对心脏的危害更大, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=19e115346ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469812, encodeId=33031469812fd, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=Stem cells：TLR4-PAR1轴调控实验性细菌性肺炎的骨髓间充质干细胞的存活和治疗作用, objectType=article, longId=130235, objectId=c0551302352a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0551302352a, replyNumber=0, likeNumber=62, createdTime=2018-02-22, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0551302352a, moduleTitle=Stem cells：TLR4-PAR1轴调控实验性细菌性肺炎的骨髓间充质干细胞的存活和治疗作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0551302352a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469811, encodeId=c984146981193, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=细菌性肺炎 VS 病毒性肺炎，判断就是这么简单！, objectType=article, longId=68300, objectId=baf668300a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baf668300a8, replyNumber=0, likeNumber=71, createdTime=2016-05-18, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baf668300a8, moduleTitle=细菌性肺炎 VS 病毒性肺炎，判断就是这么简单！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=baf668300a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469810, encodeId=c7371469810d2, content=<a href='/topic/show?id=9a5ee80979f' target=_blank style='color:#2F92EE;'>#细菌性肺炎#</a>, objectTitle=PNAS：流感继发细菌性肺炎研究获进展, objectType=article, longId=45251, objectId=b4304525156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4304525156, replyNumber=0, likeNumber=89, createdTime=2015-01-11, rootId=0, userName=pcw108, userId=52a57073433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4304525156, moduleTitle=PNAS：流感继发细菌性肺炎研究获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b4304525156)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细菌性肺炎

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#革兰氏阴性菌# #细菌性肺炎#

多重耐药革兰氏阴性菌肺炎病原学、危险因素和耐药机制

2024-10-01发表于上海

一叶知秋 (审核中...)

前往app查看评论内容

#细菌性肺炎#

J INTERN MED：乙酰水杨酸与细菌性肺炎球菌性肺炎患者生存率有关

2022-03-25

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

AJRCCM：新冠肺炎机械通气患者继发细菌性肺炎的患病率？

2021-10-22

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性

2020-12-05

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好

2020-10-08

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

FDA批准默沙东的抗生素组合Recarbrio，治疗细菌性肺炎

2020-06-09

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等

2020-05-09

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

RECARBRIO（亚胺培南、西司他丁和雷巴坦）或能“力克”呼吸机相关细菌性肺炎

2020-05-08

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知

2020-03-28

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

实体器官移植术后感染诊疗技术规范（2019版） ——总论与细菌性肺炎

2019-07-25

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究

2019-07-20

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

Merck的抗生素Zerbaxa获得了FDA批准用于治疗医院获得性和呼吸机相关细菌性肺炎

2019-06-06

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请

2019-02-25

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

NEJM：Omadacycline治疗社区获得性细菌性肺炎

2019-02-14

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

【AHA2018】细菌性肺炎比病毒性肺炎对心脏的危害更大

2018-11-15

仁心济世 (审核中...)

前往app查看评论内容

#细菌性肺炎#

Stem cells：TLR4-PAR1轴调控实验性细菌性肺炎的骨髓间充质干细胞的存活和治疗作用

2018-02-22

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

细菌性肺炎 VS 病毒性肺炎，判断就是这么简单！

2016-05-18

pcw108 (审核中...)

前往app查看评论内容

#细菌性肺炎#

PNAS：流感继发细菌性肺炎研究获进展

2015-01-11

科室
- - 订阅+
  - 更多科室
工具
服务